Patient Reported Symptoms in Ovarian Cancer (PRECISION)
| Status: | Completed |
|---|---|
| Conditions: | Ovarian Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/3/2016 |
| Start Date: | June 2011 |
| End Date: | April 2015 |
Patient Reported Symptoms in Ovarian Cancer
This multicenter, observational, prospective study will include approximately 20 US-based
centers, and approximately 142 patients diagnosed with epithelial ovarian cancer, primary
peritoneal carcinoma or fallopian tube carcinoma, whose disease has recurred > 6 months
after first-line platinum-based chemotherapy (first recurrence). Patients who have completed
second-line chemotherapy and are currently in observation or undergoing bevacizumab
maintenance treatment will be eligible to participate in the study.
centers, and approximately 142 patients diagnosed with epithelial ovarian cancer, primary
peritoneal carcinoma or fallopian tube carcinoma, whose disease has recurred > 6 months
after first-line platinum-based chemotherapy (first recurrence). Patients who have completed
second-line chemotherapy and are currently in observation or undergoing bevacizumab
maintenance treatment will be eligible to participate in the study.
Inclusion Criteria:
- Histologically documented ovarian cancer, primary peritoneal carcinoma or fallopian
tube carcinoma that has recurred > 6 months after platinum-based chemotherapy
- This must be the first recurrence of the epithelial ovarian cancer, primary
peritoneal carcinoma or fallopian tube carcinoma
- Are at least two weeks but no more than 3 months after the completion of second-line
cytotoxic chemotherapy
- Are currently under observation or being treated with bevacizumab as a second-line
maintenance therapy
- Have a valid email address and access to the internet
- Provide voluntary written informed consent
- Speak and read English fluently
Exclusion Criteria:
- Current participation in a blinded clinical trial for ovarian cancer treatment.
(Participation in a trial involving only supportive care medicines and/or growth
factors is acceptable)
- Another primary diagnosis of cancer in a different site
We found this trial at
30
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials